Self-Reported Side Effects Among Reddit Users Taking Unapproved Retatrutide
Sehgal, N. K. R.; Tronieri, J. S.; Rader, B.; Ungar, L.; Guntuku, S. C.
Show abstract
Gray-market retatrutide use is increasing, but patient safety experiences remain poorly characterized. This cross-sectional analysis examined Reddit posts and comments from retatrutide-specific and broader peptide or weight-management communities through December 2025. A validated large language model classified self-reported retatrutide use and extracted author-attributed symptoms mapped to MedDRA Preferred Terms. Among 13,589 users reporting current use, 7,823 had at least one mapped symptom after exclusions. Unlike phase 2 trial findings dominated by gastrointestinal events, Reddit reports most often described appetite increase, fatigue, increased energy, nausea, food craving, insomnia, and elevated heart rate. Findings are hypothesis-generating and warrant pharmacovigilance attention.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese non-human primate model 92%
- Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs 90%
- Assessing The Net Financial Benefits Of Employing Digital Endpoints In Clinical Trials 89%
Similar papers in this journal
- Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary 93%
- Sales of over-the-counter products containing codeine in 31 countries, 2013-2019: a retrospective observational study 92%
- Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies 92%
Similar papers in this journal
- Determining prescriptions in electronic health care (EHR) data: methods for development of standardised, reproducible drug codelists 91%
- Development and Application of Pharmacological Statin-Associated Muscle Symptoms Phenotyping Algorithms Using Structured and Unstructured Electronic Health Records Data 90%
- Illustrating Potential Effects of Alternate Control Populations on Real-World Evidence-based Statistical Analyses 89%
Similar papers in this journal
- A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years 92%
- Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial 92%
- A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Protocol 91%
Similar papers in this journal
- An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach 92%
- Acute Pain Pathways: protocol for a prospective cohort study 92%
- RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.